19 May 2013
Keywords: fda, issues, approvable, letter, epix, ms-325, german
Article | 24 January 2005
German drugmaker Schering AG says that its development partner, EPIX Pharmaceuticals of the USA, has received an approvable letter from ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.